Hims Hers Health Inc is trading at $31.52 (4.5% up) as investors react to confirmed shareholder support for the company's GLP-1 strategy and long-term growth plan.
- All proposals and nine directors were approved at the June 11, 2026, annual meeting, signaling strong backing for management's strategic direction.
- The stock is extending a multi-day rally, building on yesterday's double-digit gains and ongoing optimism surrounding its March Novo Nordisk GLP-1 partnership news.